Kassam, S
Chernucha, E
O’Neill, A
Hemmaway, C
Cummins, T
Montoto, S
Lennard, A
Adams, G
Linton, K
McKay, P
Davies, D
Rowntree, C
Easdale, S
Eyre, T A
Marcus, R
Cwynarski, K
Fox, C P
Article History
Received: 7 February 2017
Revised: 29 March 2017
Accepted: 25 April 2017
First Online: 5 June 2017
Competing interests
: SK has received travel support from Gilead and a research grant from Celgene. CPF has received speaker honoraria and advisory board remuneration from Adienne Pharma/Biotech and Roche. KC has received speaker honoraria and advisory board remuneration from Adienne and Roche. SM received speaker honoraria from Roche and travel support from Gilead. All other authors declare no conflicts of interest.